Biological Assessment of a Calcium Silicate Incorporated Hydroxyapatite-Gelatin Nanocomposite: A Comparison to Decellularized Bone Matrix by Lee, Dong Joon et al.
Research Article
Biological Assessment of a Calcium Silicate Incorporated
Hydroxyapatite-Gelatin Nanocomposite: A Comparison to
Decellularized Bone Matrix
Dong Joon Lee,1 Ricardo Padilla,2 He Zhang,1 Wei-Shou Hu,3 and Ching-Chang Ko1,4
1 NC Oral Health Institute, School of Dentistry, University of North Carolina, CB 7454, Chapel Hill, NC 27599, USA
2Department of Diagnostic Sciences, School of Dentistry, University of North Carolina, CB 7454, Chapel Hill, NC 27599, USA
3Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455, USA
4Department of Orthodontics, School of Dentistry, University of North Carolina, 275 Brauer Hall, CB 7454, Chapel Hill,
NC 27599, USA
Correspondence should be addressed to Ching-Chang Ko; koc@dentistry.unc.edu
Received 31 December 2013; Revised 9 March 2014; Accepted 22 May 2014; Published 26 June 2014
Academic Editor: Mitsuo Yamauchi
Copyright © 2014 Dong Joon Lee et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Our laboratory utilized biomimicry to develop a synthetic bone scaffold based on hydroxyapatite-gelatin-calcium silicate (HGCS).
Here, we evaluated the potential of HGCS scaffold in bone formation in vivo using the rat calvarial critical-sized defect (CSD).
Twelve Sprague-Dawley rats were randomized to four groups: control (defect only), decellularized bone matrix (DECBM), and
HGCS with and without multipotent adult progenitor cells (MAPCs). DECBM was prepared by removing all the cells using SDS
and NH
4
OH. After 12 weeks, the CSD specimens were harvested to evaluate radiographical, histological, and histomorphometrical
outcomes. The in vitro osteogenic effects of the materials were studied by focal adhesion, MTS, and alizarin red. Micro-CT
analysis indicated that the DECBM and the HGCS scaffold groups developed greater radiopaque areas than the other groups.
Bone regeneration, assessed using histological analysis and fluorochrome labeling, was the highest in the HGCS scaffold seeded
with MAPCs. The DECBM group showed limited osteoinductivity, causing a gap between the implant and host tissue. The group
graftedwithHGCS+MAPCs resulting in twice asmuch new bone formation seems to indicate a role for effective bone regeneration.
In conclusion, the novel HGCS scaffold could improve bone regeneration and is a promising carrier for stem cell-mediated bone
regeneration.
1. Introduction
A critical-sized defect (CSD) is known as the smallest size
tissue defect that will not completely heal by itself over the
duration of the experiment or the life of the subject [1, 2].
A CSD caused by neoplastic, inflammatory, congenital, or
traumatic etiologies requires a mechanically stiff biomaterial
(scaffold) and a cell source (osteoblasts) for the effective
regeneration [3–5]. Current available options to repair CSD
are autografts allografts and alloplastic grafts (synthetic bone
substitutes). The autograft is the gold standard, but there are
only a few bones that can be used as donor tissue and fre-
quently result in donor site morbidity. Allografts have a high
risk of tissue rejection and potential viral or bacterial trans-
mission; moreover, poor tissue integration with host tissue
causes the grafting failure rate of 15 to 25% [6–8]. Since both
options are highly limited by the age of the donors/recipients
and their availability, the demand for synthetic bone substi-
tutes has been increasing as an alternative source for bone
regeneration.
Although hydroxyapatite (HA) is themost widely studied
stiff scaffold material, the frequency of its clinical use is
less than 10% of all bone grafting procedures due to its
unstable fixation and insufficient interaction with host tissues
[7]. Instead, hydroxyapatite composites (e.g., hydroxyapatite
plus collagen derivatives) have been developed to mimic
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biochemical and biomechanical properties of natural bone
in order to enhance osteointegration and graft healing
for potential biomedical applications [9, 10]. The rapidly
evolving technology enables the development of biomimetic
nanocomposite biomaterials that fulfill the current require-
ments of an improved bone scaffold.
Recently, a new biomimetic nanocomposite, hydroxyap-
atite gelatin-calcium silicate (HGCS), has been developed to
address the processability of the hydroxyapatite nanocom-
posite [11–13].HGCS amalgamates the hydroxyapatite-gelatin
(HG: degraded collagen) composite particles by in situ
pozzolanic formation of calcium silicate (CS), which interacts
among gelatin, silica, and calcium hydroxide (Ca(OH)
2
).
We find that HGCS improves cytocompatibility, increases
in vitro osteogenesis, and has a greater mechanical strength
when compared to previous hydroxyapatite-collagen and
hydroxyapatite-gelatin nanocomposites. Above all, the com-
pressive strength of HGCS is significantly higher than that
of HG. Notably, the CS formed by the chemical reaction
between silica and calcium hydroxide affects the mechanical
properties of HGCS scaffolds, which increased from 43.7
to 93.6MPa (unpublished in-house data). Therefore, the
addition of CS could enhance the mechanical strength. The
performance of HGCS for in vitro and in vivo ostegenesis is,
however, unknown, which fuels an additional investigation.
Another unique scaffoldmaterial is decellularized natural
bone matrix (DECBM), which has received attention due
to its natural origin and because it is expected to serve as
a rigid scaffolding material similar to HGCS. Hashimoto et
al. were the first to report a decellularization method for
rat femurs using high pressure and measured the potential
of cells to repopulate the bone [14]. Their evaluation was
restricted to subcutaneous implantation, which requires fur-
ther investigation with the in vivo bony defect model. The
present study will develop a simplified laboratory protocol
for bone decellularization and compare the applicability of
decellularized calvarial bone matrix to HGCS using the rat
calvaria CSD model.
Both HGCS and DECBM may be stiff enough to be
utilized as scaffolds to restore bone defects. For a CSD,
however, regeneration would require production of extracel-
lular matrices by living cells. Stem cells have been known
as an ideal cell source because they are readily available,
nonimmunodeficient, and disease free when transplanted
into patients. Bone regeneration with a cell-seeded scaffold
was proven to have better regeneration potential thanwithout
cells. Bone marrow-derived mesenchymal stem cells (BM-
MSCs) have been widely used and proved to have high
osteogenic potential both in vitro and in vivo [15, 16].
Multipotent adult progenitor cells (MAPCs) are adult stem
cells originated from bone marrow as well. MAPCs can form
all three germ layers, inwhichmesodermcan give rise to bone
tissue when dexamethasone is present [17].
Since MAPCs express higher levels of stem cell makers
such as OCT-3/4, show a high proliferative rate, and can
exert immunosuppressive effects on T-cell alloreactivity and
proliferation, they are expected to become an alternative cell
source for bone tissue engineering [18–21]. MAPCs were
initially isolated from mice and rats, and specifically applied
in bone tissue engineering by Ferreira et al. MAPCs have
yielded positively in vitro osteogenic differentiation and in
vivo bone formation [22, 23].
In the present study, we developed the HGCS scaffold
and investigated its osteogenic efficiency in healing of CSDs
by comparing it with DECBM (natural matrix) and CSDs
with no graft as control. We also evaluated whether the bone
formation process using the HGCS is related to the presence
of MAPCs. Given the known positive effects of CS added
to the HG scaffold for bone regeneration, the cooperative
interaction between MAPCs and HGCS scaffold showed
facilitated bone regeneration.
2. Materials and Methods
2.1. Preparation of HGCS Scaffold and DECBM. The HGCS
scaffolds were prepared by in situ hybridization of CS with
HG powders which were biomimetically synthesized by the
coprecipitation method. The method to synthesize HAp-Gel
slurry was well described in previous studies [11]. Briefly,
the calcium hydroxide powder was mixed with HG powder
and cross-linked with enTMOS (bis [3-(trimethoxysilyl)-
propyl] ethylenediamine) for 30 seconds. To initiate the sol-
gel reaction, calcium chloride solution (48 𝜇L) was added
to the mixture. When the mixture began thickening, it
was quickly transferred into 1cc syringes with 1mm inner
diameter needles. The HGCS paste was extruded from the
syringe as intertwined threads to generate the macroporosity.
The samples were dried in air for one week and then sterilized
with ethylene oxide gas. To prepare the DECBM, the rat
calvaria were harvested (natural bone matrix: NBM) using a
trephine burr (8mm in diameter) and washed with distilled
water for 1 hour to remove blood elements. They were
placed into a decellularizing solution containing 0.5% sodium
dodecyl sulfate (SDS; Sigma-Aldrich, St. Louis, MO, USA)
and 0.1% ammoniumhydroxide (NH
4
OH: Sigma-Aldrich, St.
Louis, MO, USA) and placed on amechanical shaker at room
temperature. The detergent solution was replaced every 36
hours for 3 weeks. The completion of the decellularization
process was confirmed by histology (hematoxylin and eosin
(H&E) staining) and DNA assay. Then, the DECBM samples
were repeatedly washed with distilled water until detergents
were completely removed from the matrix. The DECBM
samples were sterilized using the same dose of gamma irra-
diation (10,000Gy) as vascular decellularized grafts before
implantation [24].
2.2. Mechanical Property of GEMOSIL-CS and DECBM. The
compressive strength of HGCS (𝑛 = 10) was determined
with the use of an Instron (model 4204, Canton, MA, USA)
and compared to HG specimens (𝑛 = 10). All samples
were prepared in a cylindrical shape with a 1 : 2 ratio of
diameter (3.5mm) to length (7.0mm). The uniaxial force
(0.5mm/min) was applied to the samples for compressive
strength, and five samples were evaluated per group. The
result was determined from the maximum strength value
on the stress-strain curve. Due to the inherent shape of the
calvaria, decellularized calvaria samples were tested using the
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three-point bending method. The strip sample, 6.3mm in
length (L) × 6mm in width (d) × 0.8mm in thickness (t), was
prepared and tested at the cross-head speed of 0.1mm/min.
The force was recorded in real time and peak force (F)
at failure was measured. The bending flexure strength of
decellularized calvaria (𝑛 = 10) was calculated by the formula
3FL/2𝑑𝑡2. The fresh calvaria samples (NBM, 𝑛 = 10) were
tested for comparison.
2.3. Thermogravimetric Analysis (TGA) of DECBM. The
decellularized and nondecellularized (natural) calvarial bone
samples were air-dried and ground to powders. Natural cal-
varial bone powders were used as controls. From each group,
10mg of powder was placed on a platinum sample holder,
which was then loaded inside the Q-500 thermogravimetric
analyzer (TA Instrument, NewCastle, DE, USA).The test was
performed in the temperature range from 30∘C to 800∘Cwith
a heating rate of 5∘C/min. Weight changes were recorded in
terms of temperature.
2.4. In Vitro Osteogenic Study of HGCS and DECBM.
MC3T3-E1 preosteoblasts were isolated from mouse cal-
varia and subcultured to test in vitro cytocompatibility and
osteogenic potential for the materials coated on the 35mm
culture dishes using P-6,000 Spin Coater (Specialty Coating
Systems, Inc., Indianapolis, IN,USA). Briefly, finely grounded
DECBM was mixed into 1mL of methanol and 44.4𝜇L of
enTMOSby voltexing for 15 seconds. ForHGCS,HG slurry in
1mL methanol was mixed with 29.6mg of Ca(OH)
2
powder
and 44.4 𝜇L of enTMOS by voltexing for 15 seconds. Then
50 𝜇L from each mixture was sprayed in the center of a
spinning 35mm dish on the spin coater and spinned for 20
seconds at 6,000 rpm.The coated dishes were sterilized under
UV for 24 hours and washed with PBS before being used.
2.4.1. Focal Adhesion Assay. MC3T3-E1 cell cytoskeletal
structures were assessed to reveal cell morphology after 3
days of cell culture on the coated dishes. Following fixation
in 4% formaldehyde, the cells were permeabilized in a 0.5%
Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) in PBS
for 5min. After blocking with 5% of BSA solution, the cells
were incubated with rhodamine phalloidin (1 : 100 ratio in
5% BSA/PBS, monoclonal, Molecular Probes, OR, USA)
and anti-𝛽-tubulin primary antibody (1 : 100 ratio in 5%
BSA/PBS, monoclonal anti-human, Sigma, UK) overnight at
4∘C.Then, the cells were thoroughly washed in 0.05% Tween
20 in PBS and incubated with FITC conjugated secondary
antibody (1 : 50 ratio in 5% BSA/PBS, Vector Laboratories,
UK) for 1 h at 4∘C. The nuclei of cells were stained with
VECTASHIELDⓇ mounting medium with DAPI (Vector
laboratories, Inc., Burlingame, CA USA) and images were
acquired using a fluorescence microscope (Nikon Eclipse Ti-
U, Nikon Instruments, Melville, NY).
2.4.2. MTS Assay. The proliferation of the MC3T3-E1
cells on the coated dishes was conducted using MTS
assay as instructed in company manual. The MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3 carboxymethoxyphenyl)-2-(4-
Sulfophenyl)-2H-tetrazolium) (Promega Co., Madison, WI,
USA) reacted with cells for an hour.Then absorbance of each
group was measured on days 1, 3, 5, 7, and 9, respectively, at
490 nm using a Plate reader (Biorad, Hercules, CA, USA).
2.4.3. Mineralization Assay. For differentiation, MC3T3-E1
cells were cultured directly on the HGCS- and DECBM-
coated 35mm dishes with osteogenic media for 4, 7, and
21 days. After washing with PBS, the cells were fixed for 10
minutes in formalin, washed, stained with 40mM Alizarin
Red (AcrosOrganics, Geel, Belgium) at pH4.2 for 10minutes,
rinsed with deionized water 6 times, and air-dried. Mineral-
ized nodule images were obtained with a Nikon Eclipse Ti-U
microscope (Nikon Instruments Inc., Melville, NY, USA).
2.5. In Vivo Implantation of Scaffolds. Rat MAPCs were
isolated, expanded, and seeded onto the HGCS scaffolds
(𝑛 = 3). The isolation, culture, and seeding on the scaffold
of rat MAPCs were described in our previous study [23].
Twelve male Sprague-Dawley rats (Charles River, Wilming-
ton, MA, about 250 g, 7 weeks) were initially anesthetized by
intramuscular injection of 10mg/kg Ketamine-HCl (Puteney
Inc., Portland, ME, USA) and additional Ketamine was
administered during experiment as needed. After shaving
and sterilizing the surgical site, an approximately 2 cm mid-
sagittal skin incision wasmade from occipital to frontal scalp,
and the subcutaneous tissue was dissected and reflected to
each side with the periosteum to expose the osseous surface
of the skull. An 8 mm CSD was created without damaging
the underlying dura and mid-sagittal blood vessels using a
low-speed dental trephine burr. Four treatment groups with
three rats each underwent surgery for a total of 12 CSDs. The
small sample size (𝑛 = 3) was chosen because this was a
screening/pilot test for a series of developing biomaterials as
indicated in our previous reports [23]. Three experimental
groups used different types of scaffolds (DECBM, HGCS
seeded with MAPCs, and HGCS). The control group con-
sisted of CSDs with no grafting at all. After implantation of
the scaffold materials, the periosteum was closed with 4–
0 chromic gut suture, and then skin was closed with 3–0
silk suture. To prevent postsurgical infection, 20mg/kg of
cefazolin (Hospira Inc., Lake Forest, IL, USA) was injected
intramuscularly once per day for 7 days after surgery. For the
mineral apposition rate (MAR) measurement, fluorochrome
labels such as Alizarin Red-S (30mg/kg, Sigma Aldrich, St.
Louis, MO, USA) and Calcein (20mg/kg, Sigma Aldrich, St.
Louis, MO, USA) were injected perivascularly to each animal
twice during the study. Alizarin Red was administered 10
days after the surgery and calcein was given 15 days before
sacrifice. The interlabeling periods were 10 and 70 days for
rats sacrificed at 12 weeks.
2.6. Micro-CT Analysis. Rats were sacrificed 12 weeks after
scaffold implantation. The calvaria were excised carefully
by preserving the implanted sites and then fixed in 10%
formaldehyde for 7 days at 4∘C. Subsequently, they were
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transferred into 70% isopropyl alcohol. The calvaria explants
were scanned by using a micro-CT system (mCT 40; Scanco
Medical, Brüttisellen, Switzerland) at 70 kV and 114mA
with a 200ms integration time. Detailed setting parameters
for acquisition and analysis of the acquired images were
described in a previous study [15]. After 3D reconstruction,
the percentage of radiopaque areas in the defects was mea-
sured using the Nikon NIS Elements software and tabulated
by treatment group. The radiopacity (%) was obtained by
dividing the new radiopaque areas in the CSD by the total
defect area. The data were presented as average ± standard
deviation. One-way ANOVAwas used to compare the means
among four groups.
2.7. Mineral Apposition Rate (MAR) by Fluorescence
Microscopy. Harvested calvaria specimens were dehydrated
and subsequently infiltrated with resin (Technovit, Heraeus
Kulzer GmbH, Germany) for 23 days. The method for the
slide preparation was described previously [20].The polished
sections were viewed using a Nikon fluorescence microscope
apparatus with bright field, TRITC and FITC filters, and a
Nikon Eclipse Ti-U digital camera (Nikon Instruments Inc.,
Melville, NY, USA). Each fluorescent image was merged to
measure the distance between fluorescent labeled layers at
the interface between native bone and the implanted scaffold
(INBS) and at the central pore area with the Nikon NIS
Elements software (Nikon Instruments Inc., Melville, NY,
USA) tools. A total of five measurements were made along
the span of each double label. TheMAR was calculated using




is the sum of all the measurements between double labels,
𝑛 is the total number of measurements, and 𝑡 is the time
(days) interval expressed [25–27]. The mean distance of the
five regions was subject to statistical analysis and the overall
mean distance was calculated for each group. Two-way
ANOVAwas used to compare the means among four groups.
2.8. Histological Determination for New Bone Tissue For-
mation. After analysis for MAR study, calvaria specimen
slides were further stained with Steven’s Blue by coun-
terstaining with Van Gieson to visualize the formation of
newly formed bone (NFB) tissue for the quantitation as
previously described [23]. Briefly, entire images of the medial
(central) sagittal histologic sectionwere acquiredwith aDP70
color digital camera equipped with color image software
(DP11, Olympus USA, Center Valley, PA, USA) under 20x
magnification and then merged using Adobe Photoshop CS6
(Adobe Systems Inc., San Jose, CA USA) to recreate as one
figure. The new bone surface area (B.Ar.) and the total area
of each defect (T.Ar.) were measured in pixels by using an
automated image analysis system (Image J software version
1.46R, NIH, Bethesda, MD, USA) to calculate the NFB (in
%: B.Ar./T.Ar/0.01) based on the standardized protocols of
the American Society for Bone and Mineral Research [28].
The one tail Student t-test was used to compare the means
between the groups.
3. Results and Discussion
The two main components of tissue engineering constructs
for in vivo implantation are the cells and the scaffoldmaterial.
Since the bone regenerating potential of MAPCs was well
reported in previous studies [18, 23], our efforts were focused
mainly on the materials aspect to compare natural and
synthetic components in bone regeneration. Previously, HG
was developed by mimicking natural bone matrix (hydrox-
yapatite and collagen derivative) with promising properties
for bone regeneration [29]. However, the weak bonding
force between HG particles and siloxane was prone to brittle
fracture and resulted in a relatively low compressive strength
when compared to natural bone. Applying CS to HG created
a new scaffold material, HGCS, which not only reinforced
its mechanical strength but also improved osteoblast adhe-
sion, proliferation, and differentiation by the stimulation of
released calcium ions. Another value of this study was to
apply a naturally derived biomaterial via removing cellular
components from the matrix for the bone regeneration.
DECBM was expected to be an ideal candidate for a scaffold
due to its function as supporting structure and regulator
of cellular functions such as cell viability, proliferation, and
differentiation [30–33]. Indeed, the natural ECM is known
to have a modulatory effect of signal transduction triggered
by bioactive molecules (growth factors and cytokines) [34,
35]. It could be preserved even after decellularization, as
described in previous applications on various tissues [36,
37]. Here, we developed an allogenic natural bone scaffold
using a decellularization technique to compare it with a
synthetic scaffold (HGCS) for the potential of in vivo bone
regeneration.
3.1. Characterization of DECBM and HGCS. The duration of
the decellularization process for rat calvaria was optimized
by 0.5% SDS and 0.1% NH
4
OH dissolved in distilled water
[38, 39]. This process effectively disrupted cell membranes
and cleaved DNA to minimize immunological rejection.
The completion of decellularization was confirmed by his-
tology and DNA assay. After 2 weeks, H&E staining of
the decellularized tissue revealed absence of both nuclei
and cytoplasmic compartments (Figures 1(a) and 1(b)) and
no DNA was detected from agarose gel electrophoresis
(Figure 1(e)). Removing the cells from thematrix is an impor-
tant step because it may prevent humoral immune reactions
against membrane proteins. It is also important to completely
remove DNA from the matrix because it can stimulate the
immune system by activating cytokine production and B-
cell immunoglobulin secretion after allogenic or xenogenic
implantation [40]. Scanning electron microscope (SEM)
evaluation revealed that both matrices exhibited similar
morphology in the distribution of collagen and mineralized
fibers residing in the matrix (Figures 1(c) and 1(d)). In NBM
cells are attached and embedded into the matrix; in DECBM
cells are absent, confirming the effective decellularization
from the calvarial bone tissue.
The TGA data reveals the typical pattern of mineral tis-
sues with a higher inorganic to organic ratio in DECBM than
in NBM (Figure 2(b)). Absorbed water inside the DECBM





Figure 1: Decellularized rat calvaria. Hematoxylin and eosin-stained cross-section of calvaria before (a) and after (b) decellularization (scale
bar: 50𝜇m). SEM analyses visualize the presence of cells in NBM (c) and the maintained ECM structure after decellularization (d); scale bar:
50 𝜇m. DNA assay was used to detect any residual DNA before (lane A) and after the decellularization of calvaria (lane B). Gross image of rat
calvaria after the decellularization process (f); scale: 1mm.
and NBM could be removed completely by heating to 200∘C.
The weight loss of the samples was attributed to the thermal
degradation of proteins including collagen, noncollagenous
proteins, and cell membranes (300–560∘C) [41]. The NBM
samples indicated a continuous weight drop from 300 to
550∘C. The DECBM samples showed an abrupt weight drop
from 300∘C to 400∘C, ceased at 450∘C, and then followed
with a gradual weight drop until 600∘C. The final weight
remainder represents the percentage of inorganic content in
the matrix. In fact, the final weight % of DECBM (65%)
was greater than that of NBM (58%), indirectly verifying
that approximately 7% of the organic contents were removed
through the decellularizing process.
The integrity of the bone matrix directly associated
with mechanical strength was measured by the three-point
bending test and the compression test in DECBM and
HGCS, respectively. The mean values of the three-point
bending test were 72.00 ± 14.14MPa and 89.36 ± 17.34MPa
for decellularized and nondecellularized bones, respectively
(Figure 2(a)). The decellularization process decreased the
mechanical strength by 19.42% (𝑛 = 10, 𝑃 < 0.05) in
DECBM compared to NBM. The difference was possibly
caused by an enzymatic effect on the structural proteins
and more likely due to a loss of soluble protein by SDS
during the decellularizing process. SDS was considered to
be a better choice than nonionic agents to thoroughly









































Figure 2:Three-point bending test of natural bone matrix (NBM) versus decellularized bone matrix (DECBM) of calvaria with a sample size
𝑛 = 5 (a). Samples were maintained hydrated with PBS during experiment. The strength was decreased by 19.42MPa after decellularization
(𝑃 < 0.05). A typical TGA result showed the weight loss versus temperature. Distinct weight drop patterns are attributed to the degradation
of water (initial drop in the curve prior to 100∘C) and organic materials (second drop at 300) (b).
remove soluble proteins from the matrix in such a hard
and compact tissue like bone (in-house nonpublished data).
The compressive strength of HGCS was significantly higher
than that of HG. Certainly, CS played a role in increasing
this mechanical property of the HGCS scaffold from 43.7 to
93.6MPa (in-house nonpublished data). This reinforcement
is attributed to the in situ formation of CS due to the chemical
reaction between silica and calcium hydroxide. Therefore,
both DECBM and HGCS implants can provide strength
approaching that of natural bone though the values were still
inferior to natural bone.
3.2. In Vitro Osteoblasts Attachment, Growth, and Osteogenic
Differentiation on DECBM- and HGCS-Coated Dishes. To
understand osteoblast-scaffold interactions, their in vivo
bioactivity, and cell integration within the scaffold material
during bone regeneration, thematerials were assessed in vitro
by culturing osteoblasts directly on HGCS and grounded
DECBM-coated dishes. Prior to use, the quality of the coating
was confirmed by observing them under a microscope
for even distribution of the materials and consistency of
coating. In the control group (no-coating), the focal adhesion
assay with MC3T3-E1 preosteoblasts generally indicated a
round cell morphology in which their actin filaments were
spread out in multiple directions by attaching with well-
distributed vinculins in the dish (Figure 3(a)). Cells grown
on the DECBM- and HGCS-coated dishes demonstrated less
spreading but still had similar morphology as the control
group cells. Most of the vinculins were observed near or on
the material particles, which supports DECBM and HGCS as
being good substrates for cell attachment (Figures 3(b) and
3(c)). MTS assay and mineralization studies were performed
for in vitro osteogenic potential with MC3T3-E1 cells on
material-coated dishes. Since a higher number of cells rep-
resent a higher formazan activity, we analyzed the MTS assay
for the cell proliferative potential by measuring the formazan
activity over time. Figure 3(d) shows the MTS activity of
the MC3T3-E1 cells measured on days 1, 3, 5, and 7. The
number of cells on both DECBM- and HGCS-coated dishes
increased up to 7 days. Cells on HGCS-coated dishes showed
a higher proliferative potential than those on DECBM, but
less potential than those of the control group between days 1
and 7. The lower growth potential on DECBM compared to
the control group was partially due to the growth behavior
of the cells on the coated matrix. The topography of DECBM
coatings would delay the cell growth in early time points due
to an increased surface area, but the cells grew similarly to
the control group after 7 days. The cells on DECBM grew
by aggregating around DECBM particles and formed thread-
like collagen structures (data not shown), which resulted in a
multilayered cell culture, unlike HGCS and control groups.
Mineralization was evaluated by nodule formation on
days 7, 14, and 21 after differentiation with the osteogenic
media (𝛼-MEM with 10mM 𝛽-glycerophosphate (Sigma-
Aldrich, St. Louis, MO, USA) and 0.2mM ascorbic acid
(Sigma-Aldrich, St. Louis, MO, USA)). In the controls,
calcium nodules were visible 14 days after differentiation
and became darker and larger at 21 days, consistent with
the typical mineralization pattern of MC3T3-E1 cells under
our differentiation conditions (Figure 3(e)). DECBM-coated
dishes showed earlier nodule formation and overall were
more intense and larger than in the control dish at days 14 and
21 (Figure 3(g)). However, themicroscopic pattern of calcium
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Figure 3: In vitro assessment of osteoblast activity on the material-coated dishes. (1) Focal adhesion assay of MC3T3 cells on the coated
culture plate with no coating as control (a), HGCS (b), and DECBM (c) after 3 days of culture. MTS assay for MC3T3-E1 cell proliferation on
the coated culture plate with DECBM, GEMOSIL-CS, and no coating as control on 1, 3, 5, and 7 days of culture (d). Mineralized nodules were
detected by Alizarin Red staining after culturing MC3T3 cells with osteogenic media on the coated culture plate with no coating as control
(e), HGCS (f), and DECBM (g) after 7, 14, and 21 days. Negative control was also tested as coated culture plate without cells for 21 days with
osteogenic media.
deposition on the HGCS-coated dish was very different than
on the DECBM and the control dishes (Figure 3(f)). Cells
on the HG started to form small nodule particles, which
then enlarged and surrounded the Ca(OH)
2
particles (white
arrows). Alizarin Red staining revealed that Ca(OH)
2
parti-
cles were located in the middle of most nodules and likely
promoted osteogenic differentiation by providing calcium
ions. Ca(OH)
2
-coated dishes without cells were also stained
to serve as negative control.
3.3. In Vivo Bone Regeneration (Mineral Apposition Rate).
Four groups were tested for bone regeneration in the rat
calvaria critical-sized defect model: empty defects (con-
trol group), DECBM, HGCS scaffolds seeded with MAPCs
(HGCS+MAPCs), and HGCS scaffolds only. After 12 weeks
of postimplantation, the entire calvarial was harvested for
MAR, gross, radiographic, and histomorphometric analyses.
To evaluate the bone formation rate, MAR was assessed by
measuring a total of six randomly selected points along the
span of each scaffold. These were double-labeled at both the
interface between the host tissue and the scaffold (IBHS) and
in the middle of the defect where healing bone infiltrated
into the porous scaffold (SID). The results of fluorochrome
labeled histology (a to d) and the MAR measurements (e)
are presented in Figure 4. At the IBHS, both HGCS+MAPCs
and HGCS groups demonstrated higher MAR values (2.72 ±
0.34 𝜇m/day and 2.67 ± 0.2 𝜇m/day, resp.) than the empty
defect control group, which had MAR of 1.6 ± 0.53 𝜇m/day.
In addition, the MAR value in the DECBM group was 0.87 ±
0.07 𝜇m/day, which was the lowest rate of mineral apposition.
At the IBHS of the DECBM group, only a few areas expressed
the fluorochromes, signifying that osteoblasts were scantly
present and that therewas lowosteoblastic activity. According
to the previous study by Parfitt et al., the total rate of bone
formation was affected by the number of osteoblasts and the
average volume of matrix secreted by the osteoblasts [42, 43].
























Figure 4: Fluorescence image of histological cross-section represented fluorochrome-labeled mineral deposition in defect (a), DECBM (b),
HGCS with MAPCs (c), and HGCS (d). Calcein (green) and Alizarin Red (red) were administered in series. Mineral apposition rate (MAR)
at the interface between host bone-scaffold (IBHS) and inside scaffold in the defect (SID) was determined at 12 weeks after implantation of
scaffolds (e). Data are shown asmean ± SD of three independent experiments,𝑃 < 0.05 (scale bars: 1mm).White arrows represent themargin
of the defect.
The highest MAR in the SID was in the HGCS+MAPCs
group (1.02 ± 0.23 𝜇m/day). The MAR in the HGCS-only
group (0.82 ± 0.1 𝜇m/day) was greater than in the DECBM
group (0.41 ± 0.1 𝜇m/day). The difference in MAR between
the HGCS group and the HGCS+MAPCs group may be
due to the MAPCs differentiating into osteoblasts in vivo,
therefore increasing their activity and the rate of bonemineral
apposition in the SID.TheMAR of the DECBM group in the
SID can only be measured on the surface of the DECBM and
not inside of the scaffold. In the control group, theMAR in the
SID could not be calculated because the empty defects did not
heal after 12 weeks (Figure 4(e)).
Overall, the HGCS+MAPCs and HGCS groups showed
increasedMAR over the DECBM and the empty defect (con-
trol) groups. In addition, the MAR in the DECBM group was
only detectable on the surface of theDECBM. Fluorochromes
were observed to be deposited only on the surface of the
DECBM scaffold because DECBM has inadequate pores;
there was no cell migration into the matrix to regenerate
bone. In the HGCS with and without MAPCs groups, fluo-
rochrome labels could be seen extensively with measureable
distances, whereas the empty defect group had them only at
the periphery of the defect. Although MAR was a significant
indicator formineral apposition rate at a specified timeframe,
further assessment by histomorphometry and radiographic
analysis can provide more information regarding the total
new bone formation (NBF).
3.4. In Vivo Bone Regeneration (Histomorphometry and 3D
Micro-CT Evidence). After fluorochrome imaging, the unde-
calcified resin sections were stained with Steven Blue andVan
Gieson histochemistry to identify new bone formation (fresh
red) in the defect site. Histological evaluation demonstrated
that the defect within the HGCS+MAPCs group was filled
with new bone that bridged with the host bone by 12 weeks.
In the HGCS scaffold-only group new bone was moderate,
primarily at the periphery of the defect (Figure 5(c)). From all
























Figure 5: Histological sections were processed for sagittal section of the defect area after 12 weeks of implantation and stained with Steven
Blue and Van Gieson.The representative section was shown from each group of defects (a), DECBM (b), HGCS with MAPCs (c), and HGCS
(d).The area of new bone formation (NFB) was quantified in % using Image J software (e). White asterisk indicates HGCS material, 𝑃 < 0.05
(scale bars: 1mm). Black arrows represent the margin of the defect.
perspectives, bone regenerationwas prominently better in the
HGCS+MAPCs group (Figure 5(d)). At 12 weeks of postim-
plantation, quantitative measurements of NBF demonstrated
56.99 ± 30.44% bone regeneration for the HGCS+MAPCs
group, 24.44 ± 3.94% for the HGCS-only group, 14.45 ±
3.94% for the DECBM group, and 21.51 ± 8.60% for the
empty defect group. Notably, the newly formed bone in both
the HGCS-only and the HGCS+MAPCs groups was well
integrated at the interface between host bone and the scaffold.
In the middle section of the HGCS-only group, the NBF in
the area of macrospores had little calcified tissue; instead
fibrous tissues were seen (Figure 5(c)). Contrastingly, the
macroporous spaces in the HGCS+MAPCs were filled with
newly formed bone tissue (Figure 5(d)). The importance of
cells in repairing bone lesions has been documented [16, 18,
23]. In this study we confirm that NBF with HGCS scaffolds
also relies on the ability of cells to increase regional bone
regeneration, especially in the central area of the CSDs apart
from host tissue (Figure 5(c)). The percentage of NBF in the
DECBM group was significantly lower than that of the HGCS
scaffold alone at 12 weeks (Figure 5(b)). Notably the empty
group also promoted NBF above that of DECBM group
(Figure 6(e)). Both the empty andHGCS groups relied on the
host bone as a cell source. The host cells may have produced
approximately 23% of NBF when there was an available space
(either defect or scaffold bridging). There was an absence
of NBF between DECBM and host tissue with intervening
fibrous tissue. In the middle of section, the NBF was slightly
formed along the outer surface of the DECBM with little
osteointegration (Figures 5 and 6). This demonstrates that
DECBM of calvarial bone does not allow cell infiltration.
In Figure 6, micro-CT analysis shows 3D reconstructed
calvaria at 12weeks after implantation (a to d).Thepercentage
of radiopaque area in the defect was calculated (e). While
the DECBM group showed the highest radiopaque area
(94.1 ± 0.31%), the HGCS+MAPCs scaffolds revealed greater
radiopaque areas (90.58 ± 0.98%) than HGCS scaffolds alone
(64.76 ± 5.53%) or empty defects (54.7 ± 0.79%). The micro-
CT data, except for the DECBM group, were consistent with
the histological measurements providing an indirect valida-
tion of NBF. The reason for the DECBM group difference is
due to the DECBMhaving the same inorganicmatrix content
as natural bone (Figure 6), making it difficult to differentiate
newly formed bone from DECBM radiographically.

























Figure 6: Micro-CT images of critical-sized calvarial defects at 12 weeks. Panels represent empty defect (a), DECBM (b), HGCS withMAPCs
(c), and HGCS groups (d). Radiopaque area in the defect was calculated in % (e). Data were represented as mean ± STD (𝑛 = 3, 𝑃 < 0.05).
Taken together, our in vivo analyses confirmed that
HGCS is stiff enough to support porous spaces for cell
ingrowth and is compatible with MAPCs for osteogenic
differentiation. The use of HGCS+MAPCs could facilitate
new bone formation and further advance the success of bone
regeneration. Although DECBM showed a higher osteogenic
differentiation potential thanHGCS in vitro, its application as
3D structural scaffold is limited due to the inability for cellular
migration into the compact structure of bone.
4. Conclusion
Our data support that HGCS possesses osteoinductive prop-
erties as a novel synthetic biomaterial for bone regeneration
and that seeding it with MAPCs yields a synergic effect
to enhance bone regeneration in rat calvarial critical-sized
defects.This study also confirms that the natural biomaterial,
DECBM, is not suitable as a bone scaffold. Our findings
suggest that further studies are needed to adapt optimal
microarchitectures of HGCS to promote bone regeneration
and to find alternative applications of DECBM as a scaffold
in bone regeneration.
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